Racial‐ethnic variations in phyllodes tumors among a multicenter United States cohort. Issue 3 (7th October 2022)

• Record Type: Journal Article
• Authors: Nash, Amanda L.; Thomas, Samantha M.; Nimbkar, Suniti N.; Hieken, Tina J.; Ludwig, Kandice K.; Jacobs, Lisa K.; Miller, Megan E.; Gallagher, Kristalyn K.; Wong, Jasmine; Neuman, Heather B.; Tseng, Jennifer; Hassinger, Taryn E.; King, Tari A.; Hwang, E. Shelley; Jakub, James W.; Rosenberger, Laura H.
• Is Part Of: Journal of surgical oncology. Volume 127:Issue 3(2023)
• Page Start: 369
• Page End: 373
• Publication Date: 2022-10-07
• Subjects: breast -- diagnosis -- disparity -- recurrence; Cancer -- Surgery -- Periodicals; Neoplasms -- Periodicals; 616
• DOI: 10.1002/jso.27117
• Languages: English
• ISSNs: 0022-4790

Abstract

Abstract: Background and objectives: Previous studies have identified racial‐ethnic differences in the diagnostic patterns and recurrence outcomes of women with phyllodes tumors (PT). However, these studies are generally limited in size and generalizability. We therefore sought to explore racial‐ethnic differences in age, tumor size, subtype, and recurrence in a large US cohort of women with PT. Methods: We performed an 11‐institution retrospective review of women with PT from 2007 to 2017. Differences in age at diagnosis, tumor size and subtype, and recurrence‐free survival according to race‐ethnicity. Results: Women of non‐White race or Hispanic ethnicity were younger at the time of diagnosis with phyllodes tumor. Non‐Hispanic Other women had a larger proportion of malignant PT. There were no differences in recurrence‐free survival in our cohort. Conclusions: Differences in age, tumor size, and subtype were small. Therefore, the workup of young women with breast masses and the treatment of women with PT should not differ according to race‐ethnicity. These conclusions are supported by our finding that there were no differences in recurrence‐free survival.